Severe persistent canine oral papillomatosis a multimodal approach including interferon alpha‐2B, CPV‐1 autologous vaccine, CO2 laser ablation and aggressive cryotherapy. Issue 3 (5th July 2019)

• Record Type: Journal Article
• Authors: Levinson, Matthew; Kirby, Allison; Richman, Austin; Hall, Melissa
• Is Part Of: Veterinary record case reports. Volume 7:Issue 3(2019)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2019-07-05
• Subjects: canine papilloma virus -- cryotherapy -- dogs -- dermatology -- viruses -- vaccines; Veterinary medicine -- Case studies -- Periodicals; Veterinary medicine -- Periodicals; 636.08905
• DOI: 10.1136/vetreccr-2018-000774
• Languages: English
• ISSNs: 2052-6121

Abstract

Abstract : A 3‐year‐old, 29.5 kg female, spayed, labrador retriever cross with a 5‐month history of severe, persistent papillomas affecting the oral mucous membranes was successfully treated using a multimodal approach that included staged aggressive cryotherapy. On presentation, verrucous growths varying in sizes of 2 mm–3 cm were appreciated affecting all tissues of the oral cavity. There were two alopecic, pedunculated growths with frond‐like projections approximately 4 mm by 4 mm and 1 cm by 4 mm on the left pelvic paw. While the growths on the paws resolved with minimal intervention, the oral verrucous growths remained. A combination of interferon alpha‐2B, canine papillomavirus‐1 autologous vaccine, surgical excision, carbon dioxide laser ablation and aggressive cryotherapy led to complete resolution and continued remission of the canine oral viral papillomas.